Woodline Partners’s BeOne Medicines Ltd ONC Stock Holding History

Woodline Partners’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.4M	Buy	+54,064	New	+$15.9M	0.05%	428
2026 Q1	–	Sell	-66,985	Closed	-$20.4M	–	1168
2025 Q4	$20.4M	Buy	+66,985	New	+$21.9M	0.08%	309
2025 Q1	–	Sell	-21,166	Closed	-$3.91M	–	1060
2024 Q4	$3.91M	Buy	21,166 +4,318	+26%	+$882K	0.03%	533
2024 Q3	$3.78M	Sell	16,848 -28,230	-63%	-$5.08M	0.03%	420
2024 Q2	$6.43M	Buy	+45,078	New	+$6.95M	0.06%	309
2023 Q3	–	Sell	-21,816	Closed	-$3.89M	–	769
2023 Q2	$3.89M	Sell	21,816 -64,729	-75%	-$14.9M	0.05%	334
2023 Q1	$18.7M	Buy	+86,545	New	+$20.8M	0.25%	112

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners's ONC Position: Q2 2026 in Review

Woodline Partners opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 54,064 shares worth $15.4M. The stake represents 0.05% of the portfolio and ranks #428 among its holdings. This is a return to the name: Woodline Partners previously reported a position in ONC as recently as Q4 2025.

Woodline Partners first reported a position in ONC in Q1 2023 and has held it in 7 quarters since. The position peaked at $20.4M in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Woodline Partners held 54,064 shares of BeOne Medicines Ltd worth $15.4M as of Q2 2026.
BeOne Medicines Ltd was a new Woodline Partners position in Q2 2026.
BeOne Medicines Ltd made up 0.05% of Woodline Partners's portfolio in Q2 2026, its #428 holding.
Woodline Partners first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 7 quarters since.
Woodline Partners's BeOne Medicines Ltd position peaked at $20.4M in Q4 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.